Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
70% of prostate carcinomas occur in peripheral zone
Transrectal ultrasonography (TRUS)
Hypoechoic lesion in peripheral zone
Multiparametric MR imaging
Classification of lesions according to Prostate Imaging Reporting and Data System (PI-RADS)
5 categories of risk for clinically significant cancer from PI-RADS 1 = very low, to PI-RADS 5 = very high
T1WI
Persistent blood from biopsy shows high signal intensity
T2WI
Peripheral zone: Hypointense mass ± extracapsular extension
Transition zone: Hypointense lenticular, noncircumscribed mass
Extracapsular extension: Breech of capsule, obliteration of rectoprostatic angle, invasion into neurovascular bundle and seminal vesicles
DWI
Focal, markedly hypointense on ADC and markedly hyperintense on high (> 1,400) b-value DWI
DCE
Focal enhancement earlier or contemporaneous with adjacent gland
MRS
↓ citrate level; ↑ choline level
↑ choline + creatine:citrate ratio
Benign prostatic hyperplasia (BPH)
Bladder carcinoma
Prostatitis
> 95% of tumors are adenocarcinoma
Most common noncutaneous cancer in American men
2nd most common cause of cancer deaths in men after lung cancer
Most important factor affecting choice of treatment is establishing likelihood of clinically localized disease
Prostate cancer (PC)
Peripheral zone (PZ)
Transition zone (TZ)
Central zone (CZ)
Diffusion-weighted imaging (DWI)
Apparent diffusion coefficient (ADC)
Dynamic contrast enhanced study (DCE)
Prostate cancer
Malignancy of prostate gland
> 95% of tumors are adenocarcinoma
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here